Literature DB >> 19356753

Ovarian hyperstimulation syndrome: steps to maximize success and minimize effect for assisted reproductive outcome.

Puja S Gera1, Laura L Tatpati, Michael C Allemand, Mark A Wentworth, Charles C Coddington.   

Abstract

OBJECTIVE: To investigate the strategies used to decrease the risk of ovarian hyperstimulation syndrome (OHSS) and their impact on pregnancy and live birth rates.
DESIGN: Retrospective cohort analysis.
SETTING: University hospital. PATIENT(S): One hundred eighty-eight patients undergoing fresh in vitro fertilization (IVF) cycles between 2000 and 2004, with peak serum estradiol levels >2500 pg/mL and presumed to be at risk for OHSS. INTERVENTION(S): Coasting and elective embryo cryopreservation were evaluated for their effect on OHSS and live birth rates. MAIN OUTCOME MEASURE(S): Pregnancy, live birth rates, and OHSS incidence. RESULT(S): Out of 188 patients at risk for OHSS, 21 patients had their cycles coasted (group 1), and elective embryo cryopreservation was performed in 32 patients (group 2). In 135 patients with no other risk factors, ovulation was triggered with human chorionic gonadotropin and embryo transfer was performed (group 3). The incidence in our IVF population was 38 out of 1002 (3.8%). The overall incidence of OHSS for those who had an estradiol level >2500 pg/mL was 20.2% (38 out of 188), and none of the patients in group 1 developed OHSS; 13 out of 32 patients in group 2 (40.6%) and 25 out of 135 (18.5%) patients in group 3 developed OHSS. The live birth rate was 38%, 40%, and 45% in groups 1, 2, and 3, respectively, and the cumulative live birth rate was 52%, 75%, and 59%, respectively. CONCLUSION(S): Elective cryopreservation of embryos with subsequent frozen embryo transfer and coasting are effective ways of maximizing pregnancy and limiting severe OHSS. Copyright (c) 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19356753     DOI: 10.1016/j.fertnstert.2009.02.049

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  17 in total

Review 1.  The use of in vitro fertilization in the management of male infertility: what the urologist needs to know.

Authors:  Sahar M Stephens; Daniel M Arnett; Randall B Meacham
Journal:  Rev Urol       Date:  2013

Review 2.  Ovarian hyperstimulation syndrome: pathophysiology and prevention.

Authors:  Carolina O Nastri; Rui A Ferriani; Isa A Rocha; Wellington P Martins
Journal:  J Assist Reprod Genet       Date:  2010-02-06       Impact factor: 3.412

3.  Increased incidence of post-term delivery and Cesarean section after frozen-thawed embryo transfer during a hormone replacement cycle.

Authors:  Kazuki Saito; Kenji Miyado; Kenji Yamatoya; Akira Kuwahara; Eisuke Inoue; Mami Miyado; Maki Fukami; Tomonori Ishikawa; Takakazu Saito; Toshiro Kubota; Hidekazu Saito
Journal:  J Assist Reprod Genet       Date:  2017-01-20       Impact factor: 3.412

4.  Pronuclear embryo cryopreservation experience: outcomes for reducing the risk of ovarian hyperstimulation syndrome and for fertility preservation in cancer patients.

Authors:  Mary E Sabatini; Ann M Wolkovich; Eric A Macklin; Diane L Wright; Irene Souter; Thomas L Toth
Journal:  J Assist Reprod Genet       Date:  2010-11-24       Impact factor: 3.412

5.  Retrospective comparison of pregnancy outcomes of fresh and frozen-warmed single blastocyst transfer: a 5-year single-center experience.

Authors:  Federico Cirillo; Leonora Grilli; Camilla Ronchetti; Ilaria Paladino; Emanuela Morenghi; Andrea Busnelli; Paolo Emanuele Levi-Setti
Journal:  J Assist Reprod Genet       Date:  2021-11-26       Impact factor: 3.412

6.  Avoiding OHSS: Controlled Ovarian Low-Dose Stimulation in Women with PCOS.

Authors:  D Fischer; C Reisenbüchler; S Rösner; J Haussmann; P Wimberger; M Goeckenjan
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-06       Impact factor: 2.915

7.  Genome-wide screening differential long non-coding RNAs expression profiles discloses its roles involved in OHSS development.

Authors:  Haiyan Lin; Yu Li; Weijie Xing; Qi Qiu; Wenjun Wang; Qingxue Zhang
Journal:  J Assist Reprod Genet       Date:  2018-06-04       Impact factor: 3.412

Review 8.  Dose adjustment of follicle-stimulating hormone (FSH) during ovarian stimulation as part of medically-assisted reproduction in clinical studies: a systematic review covering 10 years (2007-2017).

Authors:  Human Fatemi; Wilma Bilger; Deborah Denis; Georg Griesinger; Antonio La Marca; Salvatore Longobardi; Mary Mahony; Xiaoyan Yin; Thomas D'Hooghe
Journal:  Reprod Biol Endocrinol       Date:  2021-05-11       Impact factor: 5.211

Review 9.  Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment.

Authors:  Klaus Fiedler; Diego Ezcurra
Journal:  Reprod Biol Endocrinol       Date:  2012-04-24       Impact factor: 5.211

10.  Serum FSH Levels in Coasting Programmes on the hCG Day and Their Clinical Outcomes in IVF ± ICSI Cycles.

Authors:  Srisailesh Vitthala; Jerome Bouaziz; Amanda Tozer; Ariel Zosmer; Talha Al-Shawaf
Journal:  Int J Endocrinol       Date:  2012-02-12       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.